D
Diego Marquez-Medina
Researcher at Hospital Universitari Arnau de Vilanova
Publications - 16
Citations - 147
Diego Marquez-Medina is an academic researcher from Hospital Universitari Arnau de Vilanova. The author has contributed to research in topics: Lung cancer & Pemetrexed. The author has an hindex of 7, co-authored 15 publications receiving 129 citations.
Papers
More filters
Journal ArticleDOI
Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer.
TL;DR: The clinical development of afatinib is reviewed through the LUX-Lung trials portfolio highlighting benefits and toxicities and represents a step change between reversible first-generation and future irreversible highly specific third-generation EGFR-TKIs.
Journal ArticleDOI
Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy
TL;DR: The role of γδ T-cells in oncology is reported, focusing in their potential applications for cancer treatment.
Journal ArticleDOI
Pleural epithelioid hemangioendothelioma in an elderly patient. A case report and review of the literature.
Diego Marquez-Medina,Juan Carlos Samamé-Pérez-Vargas,Noemi Tuset-DerAbrain,Angeles Montero-Fernández,Teresa Taberner-Bonastre,José M. Porcel +5 more
TL;DR: The case of an 85 years old male patient diagnosed of pleural epithelioid hemangioendothelioma, taking advantage to review exhaustively literature and therapy for the disease is reported.
Journal ArticleDOI
Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases
TL;DR: Being approved for the first-line treatment of non-squamous advanced NSCLC, the addition of bevacizumab should be considered for patients presenting with MPE and new promising drugs such as ramucirumab or recombinant human endostar warrant further investigation.
Journal ArticleDOI
Systemic therapy for pulmonary carcinoids
TL;DR: Current recommendations regarding systemic treatments for PCs are reviewed and discussed and the indolent nature of some PCs is not adequately considered in designing control arms.